Last reviewed · How we verify

NCT04800887

Visual Outcomes and Contrast Sensitivity in Patients Implanted With Tecnis Eyhance Intraocular Lens

Completed NA Last updated 12 October 2021
What this trial tests

NA trial testing TECNIS Eyhance intraocular lens in Intraocular Lens in 22 participants. Completed in 24 August 2021.

Timeline
12 November 2019
Primary endpoint
24 August 2021
24 August 2021

Quick facts

Lead sponsorFaculty Hospital Kralovske Vinohrady
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment22
Start date12 November 2019
Primary completion24 August 2021
Estimated completion24 August 2021
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Faculty Hospital Kralovske Vinohrady

Who can join

Adults 40 to 85, any sex, with Intraocular Lens. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare visual outcomes for various distances, reading speed, contrast sensitivity, glare occurence, defocus curve and subjective satisfaction in patients implanted with the extended depth of focus lens (Tecnis Eyhance) in one eye and monocal aspheric lens (Tecnis ZCB00) in second eye. Patients undergo visit in 3,6 and 12 months after the surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of visual acuity and optical quality between higher-order aspheric monofocal and standard introcular lenses.
    Janekova A, Polachova M, Piñero DP, Studeny P. · · 2025 · cited 2× · PMID 40256030 · DOI 10.18240/ijo.2025.04.05

Verify or expand the search:

Other recruiting trials for Intraocular Lens

Currently open trials in the same condition.

Other Faculty Hospital Kralovske Vinohrady trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04800887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing